About Juul Labs
Combating Underage Use
Regulation and Policy
Regulatory and Legislative Policies
Harm Reduction
Regulatory Filings
Disclosure and Transparency
Regulatory Filings
Juul Labs Inc - Tobacco Product Standard for Menthol In Cigarettes – Remarks As Delivered to OMB
12/05/2023
Juul Labs Inc - Response to Letter Regarding Referral of JLI’s July 2023 PMTAs to TPSAC
10/30/2023
Juul Labs Submission - Reagan-Udall Foundation's Operational Evaluation of FDA’s Tobacco Program
11/07/2022
Juul Labs Inc - Comment_Tobacco Product Standard for Menthol in Cigarettes
08/02/2022
Juul Labs Inc - Comment on Validation and Verification of Analytical Testing Methods Used for Tobacco Products; Draft Guidance for Industry; Docket No. FDA-2021-D-0756
02/22/2022
Juul Labs Inc - Comment on Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications; Docket No. FDA-2018-N-0180
10/18/2021
Juul Labs Inc - Submission_Utah Administration Rule R384-415
12/01/2020
Juul Labs Inc – Response to November 13, 2020 Letter From Subcommittee on Economic and Consumer Policy Chairman Raja Krishnamoorthi
11/17/2020
Juul Labs Inc - Comment_Request for Information on Vaping Products Associated with Lung Injuries; Dkt No FDA-2020-N-0567
06/19/2020
Juul Labs Inc - Comment_Proposed Data Collections Submitted for Public Comment and Recommendations_NYTS 2021-2023; Dkt No CDC-2019-0117
03/23/2020
Juul Labs Inc - Comment_Enforcement Priorities for ENDS and Other Deemed Products on the Market Without Premarket Authorization_Guidance for Industry; Dkt No FDA-2019-D-0661
01/31/2020
Juul Labs Inc - Comment_Premarket Tobacco Product Applications and Recordkeeping Requirements; Dkt No FDA-2019-N-2854
12/16/2019
Juul Labs Inc - Comment_Modifications to Compliance Policy for Certain Deemed Tobacco Products_Draft Guidance for Industry; Dkt No FDA-2019-D-0661
04/30/2019
Juul Labs Inc - Comment_Smoking Cessation and Related Indications_Developing Nicotine Replacement Therapy Drug Products_Draft Guidance for Industry; Dkt No FDA-2019-D-0297
04/23/2019
Juul Labs Inc - Comment_Use of Investigational Tobacco Products_Revised Draft Guidance for Industry and Investigators; Dkt No FDA-2014-D-1939
04/22/2019
Juul Labs Inc - Comment_Tobacco Product Application Review; Dkt No FDA-2018-N-3504
12/07/2018
Juul Labs Inc - Comment_Advance Notice of Proposed Rulemaking_Regulation of Flavors in Tobacco Products; Dkt No FDA-2017-N-6565
07/16/2018
Juul Labs Inc - Comment_Advance Notice of Proposed Rulemaking_Tobacco Product Standard for Nicotine Level of Combusted Cigarettes; Dkt No FDA-2017-N-6189
07/16/2018
Select International Filings
Juul Labs Submission To UK Government Consultation On Creating A Smokefree Generation And Tackling Youth Vaping
12/06/2023
Juul Labs Canada Ltd. submission to Health Canada’s Consultation on the proposed Vaping Products Reporting Regulations
07/28/2022
Juul Lab’s Submission to the Call for Evidence on the Evaluation of the Legislative Framework for Tobacco Control
06/16/2022
Juul Labs written evidence to UK Parliament Public Bill Committee on the Online Safety Bill
06/07/2022
Juul Labs Canada - Submission to Finance Canada on the Vaping Tax Consultation, Budget 2021 Tax Measures
06/29/2021
Juul Labs Submission to the APPG on Vaping’s Inquiry on Achieving a Smoke-Free UK by 2030
05/27/2021
Juul Labs Canada Ltd. submission to Health Canada’s Consultation on the Legislative Review of the Tobacco and Vaping Products Act
04/27/2022
Juul Labs submission to the "Independent review of smoke-free 2030 policies" - the Khan Review
03/21/2022
Juul Labs Submission to UK Department for Health & Social Care Regarding the Post-Implementation Review of the Tobacco and Related Products Regulations 2016
03/19/2021
Juul Labs Canada - Response to Health Canada's Proposed Concentration of Nicotine in Vaping Products Regulations (CNVPR)
03/04/2021
Juul Labs’ Consolidated Response to the Preliminary Opinion of the European Commission and its Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) on electronic cigarettes
10/26/2020
Juul Labs Submission to the Australian Senate Select Committee On Tobacco Harm Reduction
04/11/2020
Juul Labs Submission to the New Zealand Health Selection Committee on the Smokefree Environments and Regulated Products (Vaping) Bill
04/08/2020
Juul Labs Canada response to Health Canada Market Research Survey of February, 2020
02/24/2020
Juul Labs Canada response to proposed vaping regulations in British Columbia from January, 2020
01/23/2020
See Other Pages
Regulatory and Legislative Policies
Harm Reduction
Regulatory Filings
Disclosure and Transparency